This would be my train of thought as well. The "option" to license is an attractive path to pursue by both. One without the other is, well, just that. Amarantus does have venues available if both corroborate. As you say, it would/could benefit both parties...
Thank you....
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links